Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has submitted a routine compliance certificate from its Registrar and Transfer Agent, Purva Sharegistry, for the quarter ended September 30, 2025. Under SEBI Regulation 74(5), this confirms that any share certificates received for dematerialisation during the quarter were processed and the company's register of members was updated accordingly. The attached details show NIL share certificates were dematerialised during the quarter, meaning no shareholders converted physical shares into demat form. The filing was signed by Director Bhoomi Patel on October 8, 2025.
This is a standard procedural filing with no impact on shareholders or stock price. It simply confirms routine housekeeping on the demat side of shareholding records and reflects normal regulatory compliance.